Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study
Bronchiolitis
About this trial
This is an interventional treatment trial for Bronchiolitis focused on measuring Children, Nasal suction devices, Suctioning
Eligibility Criteria
Inclusion Criteria:
- patients above the age of 2 months and post-gestational age to 44 weeks and less than or equal to 2 years with signs and symptoms of bronchiolitis
- clinical respiratory score (CRS) of less than or equal to 4
- principle diagnosis of bronchiolitis (International Classification of Diseases-9: 466, 466.11 and 466.19)
- Patient admitted to the Pediatric Hospitalist Medicine (PHM) group
- Patient with associated hypoxemia and/or respiratory distress requiring low flow O2 nasal cannula (NC) management (2L/min or less)
Exclusion Criteria:
- age less than 2 months
- age less than post-gestational age 44 weeks
- CRS greater than 4
- associated hypoxia
- already using NoseFrida at home
- chronic lung disease
- oro-facial abnormalities
- cardiac abnormalities
Sites / Locations
- Texas Children's Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
NoseFrida
NeoSucker
If randomized to the NoseFrida group, the NoseFrida/filters will be given along with educational instruction of its use to the parents of patients admitted with bronchiolitis. The NoseFrida will be used by the parent to suction the nares of their infants/toddlers.
The NeoSucker (used for nasal suctioning) is part of the current standard of care for patients with bronchiolitis. The NeoSucker is used for removing nasal secretions by a nurse or respiratory therapist. The NeoSucker is a plastic tube which is used to suction the secretions. The bedside nurse will continue to use the NeoSucker as needed. NoseFrida will not be used for this sub group of patients.